NovaBay Pharmaceuticals Inc (NBY) — Cash Flow Reinvestment Rate
NovaBay Pharmaceuticals Inc (NBY) has a Cash Flow Reinvestment Rate of 0.26x as of September 2017, reinvesting $73.00K (capex $73.00K ) from operating cash flow of $281.00K. Check NBY operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
NovaBay Pharmaceuticals Inc Cash Flow Reinvestment Rate (2006–2010)
Historical reinvestment intensity for NovaBay Pharmaceuticals Inc across 2 annual periods. Explore cash flow to debt ratio of NovaBay Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for NovaBay Pharmaceuticals Inc (2006–2010)
Year-by-year capital reinvestment analysis for NovaBay Pharmaceuticals Inc. For live market cap and broader valuation context, see market value of NovaBay Pharmaceuticals Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2010 | 0.10x | $203.00K | $2.03 Million | $203.00K | ▲ +31.2% |
| 2006 | 0.08x | $362.00K | $4.74 Million | $362.00K | — |